Twitter Logo Youtube Circle Icon LinkedIn Icon

Ireland

The Legal 500 Hall of Fame Icon The Legal 500 Hall of Fame highlights individuals who have received constant praise by their clients for continued excellence. The Hall of Fame highlights, to clients, the law firm partners who are at the pinnacle of the profession. In Europe, Middle East and Africa, the criteria for entry is to have been recognised by The Legal 500 as one of the elite leading lawyers for seven consecutive years. These partners are highlighted below and throughout the editorial.
Click here for more details

Ireland > Healthcare and life sciences > Law firm and leading lawyer rankings

Editorial

Index of tables

  1. Healthcare and life sciences
  2. Leading individuals
  3. Next generation lawyers

Next generation lawyers

  1. 1

Who Represents Who

Find out which law firms are representing which Healthcare and life sciences clients in Ireland using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact david.burgess@legal500.com.

CLICK HERE TO VISIT THE WHO REPRESENTS WHO SITE

At A&L Goodbody, Cliona Christle is ‘a really capable pair of hands with a great ability to look at matters in an innovative way’; Christle is representing the State Claims Agency in the defence of High Court claims arising out of the historic practice of symphysiotomy. The practice has a significant following in the life sciences sector and in one highlight acted for SK Biotek on the purchase of Bristol-Myers Squibb’s pharmaceutical ingredients manufacturing plant. Corporate specialist David Widger is the other main contact.

Arthur Cox’s ‘very wide and complete practice’ is led on the life sciences side by Colin Kavanagh, who advised Bristol-Myers Squibb on the sale of its pharmaceutical ingredients manufacturing plant to SK Biotek. In the healthcare litigation space, the team focuses on product liability work: Joanelle O’Cleirigh is advising the Irish Blood Transfusion Service on issues arising from defects in a device used to measure haemoglobin levels, and ‘superb tacticianIsabel Foley is defending various medical devices manufacturers in personal injury claims.

ByrneWallace wins praise for its ‘depth of industry knowledge’, with life sciences practice head Colin Sainsbury singled out for his knowledge of the pharmaceutical sector. Sainsbury, who ‘outlines options clearly’, advises Q3 Medical Devices on a number of commercial and clinical trial agreements. Also on the life sciences side, senior associates Catherine Dowling and Brendan Gavin are ‘thorough, diligent and timely’. Sinéad Kearney leads on healthcare and childcare matters and regularly represents the Health Service Executive (HSE) in contentious matters.

Mason Hayes & Curran’s healthcare team is ‘tactically on top of the game’, with John Gleesona shrewd and excellent negotiator’, and former surgeon Kevin Powerskilled at giving very complex regulatory advice in a very understandable, commercial manner’. Power successfully obtained a €7.1m settlement on behalf of a client who suffered a catastrophic brain injury. Martin Kelleher leads on life sciences work and advised Sigmoid Pharma on a development, licensing and supply agreement for a new pharmaceutical product.

At Matheson, the ‘pragmatic and knowledgeableMichael Finn and

Robert O’Shea, who has ‘deep experience in working with US companies’, handle a range of corporate, IP and litigation-related mandates in the life sciences sector; Finn is defending MBR Optical Systems in an investigation regarding an alleged failure of its medical device to identify blood donors with low haemoglobin levels. In the healthcare space, Tom Hayes and Rebecca Ryan are defending clinical practitioners and their indemnity bodies in medical malpractice and negligence claims.

William Fry is probably best known for its expertise in patent litigation in the pharmaceutical, biotech and medical device fields. Laura Scott, who is ‘on top of the technical detail’, is acting for Boehringer Ingelheim in the defence of patent proceedings brought by Teva Pharmaceutical Industries. The ‘straightforward and clearFiona Barry and the ‘efficientSinead Keavey focus on healthcare litigation for clients such as Royal College of Surgeons. Scott and corporate specialist David Carthy head the practice.

Eversheds Sutherland is particularly recognised in the healthcare sector, where Aisling Gannon’s ‘expertise is second to none’; Gannon provides contentious and non-contentious advice to a range of hospitals, nursing homes, primary care centres and public sector clients. Tony McGovern leads on life sciences work and is assisting Integumen with its listing on AIM.

Hayes Solicitors has ‘one of the best healthcare practices in the country’, with the team able to ‘manage complex litigation in a systematic and methodical way’. Ciarán O’Rorke represented the State Claims Agency in a precedent-setting decision on legal costs following a catastrophic birth injuries claim. The Medical Protection Society is another key client. Practice head Mary Hough is ‘outstanding’ and Caroline Crowley is ‘highly skilled’.

McCann FitzGerald’s expertise in the life sciences sector includes an ‘excellent’ IP team, where litigator Fiona O’Beirne is the main contact, and also considerable depth in the product liability space; Roddy Bourke and David Hurley are defending DePuy International against a multitude of claims arising from an allegedly faulty hip replacement device. The practice also handled a number of significant corporate transactions for clients such as Cardinal Health.

Ronan Daly Jermyn has ‘huge expertise’ in the area of medical negligence claims, with Galway-based Padraic Brennan, Imelda Tierney and Cork-based Fergal Dennehy able to provide ‘excellent pre-trial briefs, which hone in on the crucial issues’. Corporate specialist Gillian Keating, who is also based in Cork, leads on life sciences work. The team advised Bon Secours Health System on its acquisition of Barringtons Hospital in Limerick.

Kennedys’ healthcare offering was strengthened by a number of hires including the UK- and Ireland-qualified Joanne O’Sullivan, who joined from the Royal Free London NHS Foundation Trust. The ‘proactive and robust’ O’Sullivan was active in the defence of medical negligence claims for private healthcare providers.

International Law Firm Networks

The Legal 500 Events

International Law Firm Networks

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in Ireland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • LANDWELL Bulletin: Managing in a Downturn

    As we are all well aware this is the most turbulent climate for business both nationally and internationally, that any of us have experienced. We have therefore focused this bulletin on areas where we believe we can help you take decisive steps to manage the issues that are required to get through the downturn and be properly prepared for the future.
  • The Companies (Amendment) Act 2009

    The Companies (Amendment) Act, 2009 (the “Act”) was signed into law on 12 July 2009. The Act provides for signifi cant changes to company law compliance and enforcement. It gives increased powers of search and seizure to the Offi ce of the Director of Corporate Enforcement (“ODCE”) and expands disclosure obligations with regard to transactions between a company and its directors (including specifi c changes for licensed banks). The Act also relaxes the requirement that at least one director of an Irish company must be resident in the State.
  • New Rules for Acquiring Transactions in the Financial Sector

    In line with EU-mandated requirements, Ireland has introduced new rules governing acquisitions, in whole or in part, of certain regulated financial institutions.
  • Irish Merger Control: Review of Key Developments in 2008

    A 47% Year-on-Year Drop in the Number of Deals Notified: Reflecting the global decline in merger activity, the number of deals notified to the Competition Authority fell to 38 in 2008, a 47% decrease from 2007, when 72 deals were notified, and a more than 60% decrease from the 2006 peak of 98 notified deals.
  • European Communities (Takeover Bids (Directive 2004/25/EC)) Regulations 2006

    The EU Takeovers Directive (2004/25/EC) (the “Takeovers Directive”) has been transposed into Irish law by the European Communities (Takeover Bids (Directive 2004/25/EC)) Regulations, 2006 (S. I. No. 255 of 2006) (the “Takeovers Regulations”). The stated aim of the Takeovers Directive is to strengthen the Single Market in financial services by facilitating cross-border restructuring and enhancing minority shareholder protection. Many of the provisions of the Directive are already contained in the existing Irish regime for the supervision of takeovers set out in the Irish Takeover Panel Act, 1997 (the “Act”), the Takeover Rules, 2001 (the “Rules”) and the Companies Acts 1963 – 2005, which will continue to apply. The Takeovers Regulations cater for those areas not already dealt with in the existing regime or areas of the regime that needed to be adjusted as a result of the requirements of the Takeovers Directive.
  • Establishing a Retail Fund in Ireland for sale in Japan Fund Structures and Features

    The issuing of securities of offshore funds for public sale into Japan is governed by a combination of the Securities and Exchange Law of Japan (the "SEL") which is enforced by the Japanese Ministry of Finance ("MOF"), the Law Concerning Investment Trust and Investment Company of Japan (the "Investment Funds Law") which is enforced by the Financial Services Agency of Japan ("FSA").Establishing a Retail Fund in Ireland for sale in Japan Fund Structures and Features
  • Equality before the Law

    Employment Equality legislation in Ireland is to be found in the Employment Equality Act 1998 as amended by the Equality Act 2004. This legislation is extremely detailed but in effect makes it unlawful for employers to discriminate against a person on the basis of gender, marital status, family status, sexual orientation, religion, age, disability, race, and membership of the traveller community. These are referred to as the “discriminatory grounds”.
  • Enforcement of Foreign Judgments in Ireland

    The enforcement of judgments between the EU member states is regulated by the Brussels I Regulation (44/2001, OJL 12/1, 16 January 2001) (“the Regulation”). On the 22nd December 2000, the European Council agreed the Regulation to replace the Brussels Convention on Jurisdiction and Enforcement of Judgments 1968 (“the Brussels Convention”). The purpose of the Regulation was to bring the law contained in the Brussels Convention into the main body of EC Law. The Regulation was implemented in Ireland by Statutory Instrument 52 of 2002, European Communities (Civil and Commercial Judgments) Regulations 2002, which came into force on the 1st March 2002.
  • E-Discovery

    Unlike the United States, which is leading the way in relation to e-discovery and where the disclosure of electronic data has become standard procedure, as of yet there is no standard protocol or practice direction issued in relation to e-discovery in Ireland. Despite this fact, Irish lawyers are beginning to appreciate the invaluable nature of electronic data which can be retrieved and used in commercial litigation.
  • Disclosure Requirements with respect to Company Particulars

    Directive 2003/58/EC amending Directive 68/151/EEC (the “First Disclosure Directive”) became effective on 1st April, 2007 having been transposed into Irish law by the European Communities (Companies) (Amendment) Regulations 2007 (S.I. No. 49 of 2007) (the “Regulations”).

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to